Lipella Pharmaceuticals INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
10-K: Lipella Pharmaceuticals Reports Fiscal Year 2024 Results, Outlines Clinical Development Strategy
Lipella Pharmaceuticals details its FY2024 financial results and progress in clinical trials for its lead drug candidates, LP-10 and LP-310, while addressing ongoing financial and Nasdaq compliance challenges.
OTC.Pink
Lipella Pharmaceuticals Inc. reports its 2023 financial results, highlighting progress in clinical development of its lead product candidates and ongoing research programs.